Dechra is expanding its Veterinary Essentials portfolio of veterinary licensed generics with the introduction of five new products.

Flexicam® - a NSAID for the control of pain and inflammation in dogs with acute and chronic musculo-skeletal disorders, joins the range following the acquisition of VetXX. Roger Brown, product manager at Dechra Veterinary Products said: "Flexicam provides vets with all the proven benefits of meloxicam, one of the most frequently prescribed NSAIDs."

Prednidale 25 also joins the fold as the first veterinary licensed 25mg strength prednisolone, which together with Prednidale 5, gives vets a wider variety of treatment options for inflammatory diseases, allergic diseases, some autoimmune diseases and some neoplastic conditions. Roger said: "Under the cascade system, practices currently using non-veterinary licensed 25mg strength prednisolone can now convert to using a veterinary licensed product instead."

Alongside Flexicam and Prednidale 25 is a new combination of sedation and reversal agents (Sedator® and Atipam® respectively). Sedator, which contains the active ingredient medetomidine hydrochloride, is used for sedation, analgesia and anaesthetic premedication in cats and dogs. Roger said: "This product can now be used in combination with Atipam, our new reversing agent and generic partner to Sedator. Atipam is an alpha-2-adrenoceptor antagonist which is chemically identical to the market leader, but can offer practices permanent savings of at least 37 per cent."

For further details on the new products, please contact your local Dechra territory manager or call Rachel Horton 01743 441 632.

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.